Hospitals and health systems engaged in clinical trials enjoy several benefits — the ability to provide the latest treatment options to patients, the prestige of being a research organization, as well ...
Through this collaboration, GCCL aims to expand strategic partnerships with global CROs and research organizations, strengthen its capability to deliver fully integrated clinical trial solutions ...
The report identifies opportunities in optimizing clinical trial strategies and locations, highlighting key market positions in cholera research. It aids in strategy formulation by providing insights ...
Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients ...
News-Medical.Net on MSN
Analysis reveals why head and neck cancer clinical trials end early
Head and neck cancer trials are frequently derailed before they can deliver answers. A new analysis suggests that the most common reasons are sponsor decisions related to safety or effectiveness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback